SEC Form 5 · accession 0001209191-19-010174
Biohaven Pharmaceutical Holding Co Ltd. · BHVN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Vlad Coric
Officer — Chief Executive Officer · Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 14, 2019 · 4:32 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001689813
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Shares | Jul 23, 2018 | G | 35,000 | $0.00 | D | 490,000 | I | By The Vladimir Coric Marital Trust 2013 |
| Common Shares | holding | — | — | — | 525,000 | I | By The Vladimir Coric Family Trust 2013 |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $32.42 | Nov 20, 2018 | A | 200,000 | A | — | Nov 19, 2028 | Common Shares | 200,000 | 200,000 | D |
Explanation of responses
- F1The shares underlying this option vest in four equal installments on November 20, 2019, 2020, 2021 and 2022, subject to the reporting person's continuous service with the issuer at each vesting date.